(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BAUDAX BIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BAUDAX BIO

ST13

US500000088980224

Class

5, 42

Filing

88980224

Registration

6297070

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

03/17/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

10/01/2019

Registration date

03/16/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/16/2021

Last transaction

03/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/30/2020

First use in commerce

03/30/2020

Drawing code

3

Owner type

03

Owner location

Malvern, PA, US

Examiner

LAVOIE, RYAN CHRISTOPHER

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording BAUDAX BIO in stylized font with a triangle above the X.

Holders and representatives

Holders

Baudax Bio, Inc.

Representatives

Lori Harrison TROUTMAN PEPPER HAMILTON SANDERS LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biological preparations for medical or pharmaceutical usepreparations for the treatment of acute critical care conditions; pharmaceutical preparations for the treatment of acute critical care conditions; pharmaceutical preparations for the prevention and treatment of pain; pharmaceutical preparations for the treatment of pain management by intravenous or intramuscular delivery

Class 42

Development of pharmaceutical and biological preparations

Publications

History of USPTO decisions and trademark events.

37 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/16/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/26/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

01/26/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/26/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/26/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

03/16/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/09/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/06/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/16/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/15/2021

DPCC

DIVISIONAL PROCESSING COMPLETE

01/15/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/11/2021

IUAF

USE AMENDMENT FILED

12/22/2020

DRRR

DIVISIONAL REQUEST RECEIVED

12/22/2020

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

12/22/2020

EISU

TEAS STATEMENT OF USE RECEIVED

12/22/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/09/2020

PUBO

PUBLISHED FOR OPPOSITION

06/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/29/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/27/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/27/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/27/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/21/2020

GNRT

NON-FINAL ACTION E-MAILED

04/21/2020

CNRT

NON-FINAL ACTION WRITTEN

04/21/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/28/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/27/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/27/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/13/2020

GNRT

NON-FINAL ACTION E-MAILED

01/13/2020

CNRT

NON-FINAL ACTION WRITTEN

01/13/2020

DOCK

ASSIGNED TO EXAMINER

01/06/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/05/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/04/2019

NWAP

NEW APPLICATION ENTERED

10/04/2019

Continuous trademark protection

Get notified about every new filing that threatens BAUDAX BIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.